Aurobindo Pharma Ltd

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 201903 Annual Report Page No: 147)

Pros:
Cons:
The company has delivered a poor growth of 11.51% over past five years.
Company has high debtors of 155.79 days.

Peer Comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Loading peers table ...

Quarterly Results Standalone Figures in Rs. Crores / View Consolidated

Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019
2,410 2,521 2,420 2,188 3,074 2,686 2,355 2,559 3,170 3,248 3,281 3,079
1,817 1,887 1,840 1,700 2,035 2,022 1,877 2,162 2,563 2,650 2,546 2,528
Operating Profit 593 634 580 489 1,039 664 478 397 607 598 734 550
OPM % 25% 25% 24% 22% 34% 25% 20% 16% 19% 18% 22% 18%
Other Income 35 29 51 12 29 34 6 3 4 137 28 30
Interest 12 10 9 10 12 13 17 24 31 41 35 32
Depreciation 71 71 73 83 90 90 92 94 101 109 109 115
Profit before tax 545 582 549 407 966 595 375 282 479 585 618 433
Tax % 23% 24% 17% 24% 22% 25% 18% 20% 21% 21% 26% 24%
Net Profit 419 441 455 307 753 444 308 225 381 464 460 330
EPS in Rs 7.16 7.53 7.78 5.25 12.85 7.58 5.26 3.84 6.50 7.91 7.85 5.64
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
2,276 2,749 3,195 4,130 4,277 5,424 7,108 8,069 9,158 9,607 10,270 12,258 12,778
1,917 2,500 2,497 3,173 3,704 4,466 5,187 5,816 6,705 7,215 7,600 9,838 10,288
Operating Profit 359 250 698 957 573 958 1,922 2,253 2,453 2,392 2,670 2,420 2,490
OPM % 16% 9% 22% 23% 13% 18% 27% 28% 27% 25% 26% 20% 19%
Other Income 119 75 172 29 -300 27 73 65 187 118 81 189 200
Interest 59 81 63 55 268 250 289 132 229 45 53 231 139
Depreciation 75 82 95 125 143 171 186 245 263 286 355 413 435
Profit before tax 345 161 712 805 -138 563 1,519 1,940 2,148 2,179 2,343 1,965 2,116
Tax % 16% 20% 26% 26% 69% 12% 23% 22% 24% 22% 23% 22%
Net Profit 291 129 526 594 -43 496 1,172 1,516 1,627 1,707 1,813 1,530 1,635
EPS in Rs 5.35 2.32 9.35 10.04 0.00 8.40 19.85 25.54 27.80 28.73 30.94 26.11 27.90
Dividend Payout % 6% 19% 5% 10% -68% 9% 7% 9% 9% 9% 8% 10%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:16.12%
5 Years:11.51%
3 Years:10.21%
TTM:19.71%
Compounded Profit Growth
10 Years:28.53%
5 Years:5.56%
3 Years:-1.87%
TTM:-5.52%
Stock Price CAGR
10 Years:18.30%
5 Years:0.31%
3 Years:-16.95%
1 Year:-38.69%
Return on Equity
10 Years:22.18%
5 Years:21.44%
3 Years:18.42%
Last Year:14.42%

Balance Sheet Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
27 27 28 29 29 29 29 29 59 59 59 59
Reserves 1,194 1,294 1,886 2,540 2,464 2,910 3,983 5,330 6,807 8,378 9,924 11,292
Borrowings 1,756 2,115 1,945 2,318 2,794 2,782 2,925 3,285 4,165 3,054 3,719 4,520
538 617 751 971 869 1,246 1,657 1,610 1,795 1,866 2,474 2,710
Total Liabilities 3,514 4,053 4,610 5,859 6,156 6,967 8,594 10,254 12,827 13,356 16,176 18,581
827 873 1,045 1,350 1,627 2,012 1,938 2,190 2,568 3,212 3,393 4,150
CWIP 125 286 499 537 558 166 204 227 742 907 1,144 789
Investments 288 269 371 493 629 708 873 1,013 1,183 1,682 1,968 2,339
2,274 2,625 2,694 3,479 3,343 4,081 5,580 6,824 8,333 7,556 9,671 11,303
Total Assets 3,514 4,053 4,610 5,859 6,156 6,967 8,594 10,254 12,827 13,356 16,176 18,581

Cash Flows Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
105 5 346 245 504 625 328 590 2,457 922 527
-12 -302 -408 -569 -534 -295 -401 -624 -1,542 -991 -1,297
-185 161 -14 443 -78 -229 -31 35 -1,329 440 599
Net Cash Flow -92 -136 -75 118 -108 101 -105 1 -414 371 -171

Ratios Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 14% 7% 21% 20% 9% 15% 29% 27% 24% 20% 19% 15%
Debtor Days 128 147 132 131 122 116 153 168 175 143 159 156
Inventory Turnover 3.80 3.96 3.80 3.74 3.45 4.09 4.52 4.18 4.00 3.95 3.52 3.32